15 million euros - such amount was saved by Lithuanian patients in just one year. This result was achieved through the purchase of reimbursable medicines. This is evidenced by the analysis carried out by the National Health Insurance Fund under the Ministry of Health (NHIF). Last year, the total of more than 230 million euros from the budget of the Compulsory Health Insurance Fund (CHIF) was spent for the reimbursement of medicines.
"It is a pleasure to see that changes in reimbursement of medicines that were launched in July last year, specifically the introduced "ceiling" for co-payment to the price to be paid by the patients, increased levels of reimbursement, and the price list which is compiled on a quarterly basis, seem to be bearing fruit. The analysis that was carried out by the National Health Insurance Fund showed that the residents of Lithuania have less and less to pay co-payment to the price of reimbursable medicines. A co-payment to the price of medicines to be paid by the patients decreased per year by as much as 28%. Thus, they saved nearly 15 million euros", - says Evaldas Stropus, the Head of Medicines Compensation Division of the NHIF.
According to him, in 2017 the average co-payment to the price to be paid by the patient per one prescription was 5 euros, and in last year the patient had only to pay 3.9 euros on average of co-payment to the price of reimbursable medicines.
According to the data of the analysis that was carried out by the NHIF, last year, 232 million euros were spent from the budget of the CHIF to reimburse all Lithuanian patients for medicines. That's even 14 million more than in the year before the last.
"Expenditure from the budget of the CHIF has increased considerably due to the fact that many really expensive medicines of high therapeutic value that are intended to treat oncological diseases have been started to be reimbursed last year. In comparison to other groups of medicines, last year the largest portion of the budget of the CHIF – more than 79 million euros - was spent on reimbursement of anti-tumor medicines", - says E. Stropus.
A considerable amount of funds from the budget of the CHIF was also spent on reimbursement of cardiac medicines (38 million euros), circulatory system medicines (23 million euros) and nervous system medicines (22 million euros).
The HIF recalls that from 2019, a co-payment to the price per one package of most reimbursable medicines cannot exceed 4,71 euros when the medicine is reimbursed 100 percent of the basic price. The patient may be required to cover a higher amount of a co-payment if the medicine is produced by only one producer and the producer's medicine is irreplaceable, or, and this is another exception, the producer did not consent to reduce the price of the medicine that is use in Lithuania.
According to the data of the National Health Insurance Fund, last year, about 1.17 million patients used reimbursable medicines and medical aids, or every third resident of Lithuania.
The NHIF invites you:
Your questions are welcome by email email@example.com or phone: local (8 5) 232 2222, international +370 5 232 2222